Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | TACR1 | P25103 | 7/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CCR3 | P51677 | 3/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.45 |
| ▸ | DRD3 | P35462 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3738086 | 0.99 | TSHR (0.54) | TSHRTACR1ALDH1A1MEN1HPGD | |
| Hydrochloric Acid SCHEMBL3635175 | 0.99 | TSHR (0.54) | TSHRTACR1ALDH1A1MEN1HPGD | |
| SCHEMBL3741684 | 0.90 | TSHR (0.46) | TSHRTACR1ALDH1A1MEN1HPGD | |
| Hydrochloric Acid SCHEMBL3747861 | 0.89 | TSHR (0.45) | TSHRTACR1ALDH1A1MEN1HPGD | |
| SCHEMBL13044840 | 0.87 | TSHR (0.43) | TSHRTACR1ALDH1A1MEN1HPGD | |
| Hydrochloric Acid SCHEMBL3737450 | 0.86 | TSHR (0.42) | TSHRTACR1ALDH1A1MEN1HPGD | |
| Hydrochloric Acid SCHEMBL3737455 | 0.86 | TSHR (0.42) | TSHRTACR1ALDH1A1MEN1HPGD | |
| SCHEMBL13044863 | 0.86 | TSHR (0.42) | TSHRTACR1ALDH1A1MEN1KMT2A | |
| SCHEMBL13044855 | 0.86 | TSHR (0.42) | TSHRTACR1ALDH1A1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL3638182 | 0.85 | TSHR (0.41) | TSHRTACR1ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100286152-A1 | N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR | GLAXO GROUP LIMITED (GB) | 2010-11-11 | — | — | US | disclosed |
| US-20100286152-A1 | N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR | GLAXO GROUP LIMITED (GB) | 2010-11-11 | — | — | US | disclosed |
| WO-2008148853-A1 | N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR | GLAXO GROUP LIMITED (GB) | 2008-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286152-A1 | N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR | GIPR, GHSR, GLP1R | TSHR 47/4885TACR1 56/4885ALDH1A1 2645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.